Morning
@newB , I smell Value here , I have been taking up a position over the past week.
Multiple Phase II Trials , Fully Funded Trial Runway.
Many Biotechs go through multiple Machinations on the way to success... RAC's main oncology asset was a remnant of another company T/O , under the right Management that went from a back room cupboard to a $4 stock .
Possibly the Management "Individuals" referenced will be under "A Mandated Management Strategy" under close observation ,, You are correct positive data and solid science is where the value resides,, MC of only $22m
As always for every investor who believes the race is run and sells there is a Buyer who believes the Company is just putting on their running shoes and heading for the start line....
Best of Luck to all Investors ,, NZT
